↓ Skip to main content
What is this page? Embed badge

Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer

Overview of attention for article published in Frontiers in immunology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
1 Mendeley
Summary X Dimensions citations

This page is provided by Altmetric.